1.
Silencing CACYBP suppresses lung adenocarcinoma growth via CDK1 inhibition. Biomol Biomed [Internet]. 2025 Mar. 19 [cited 2025 Apr. 2];. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/11849